Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Impact of coronavirus pandemic on families affected by autism

The changes to social and work life required to manage the coronavirus pandemic impose huge demands on everyone but their impact has been greatest on...Read more

Bupropion evaluated for apathy associated with Alzheimer’s disease

This 12-week double-blind clinical trial from Germany compared bupropion 150 mg/day for 4 weeks then 300 mg/day for 8 weeks with placebo in 108 people with...Read more

Prescribing safety indicators for mental health

An extensive suite of indicators to assess and monitor the safety of prescribing for mental health disorders has been developed through a consensus of 31...Read more

Non-medical use of benzodiazepines and Z-drugs

Perhaps as many as 635,000 adults in the UK are using a benzodiazepine or a Z-drug (zaleplon, zolpidem, zopiclone) for a non-medical purpose, a new analysis of...Read more

Japanese herb comparable with clonazepam for sleep disorder

Rapid eye movement sleep behaviour disorder (RBD) may be a prodromal marker of Lewy body dementia and Parkinson’s disease. It is most common in elderly...Read more

The factors underpinning GP antidepressant prescribing

In 2017, one in six adults in England were prescribed an antidepressant, representing a near-doubling of prescribing rates over the preceding decade. However,...Read more

ECT meta-analyses ‘wrong’ about efficacy

About one million people have electroconvulsive therapy (ECT) every year but the quality of most of the evidence supporting its use is ‘so poor that the...Read more

Featured Articles

Mental disorders in migrants: First episode psychosis in postpartum period
The aetiology of the increased risk of mental illness in migrant populations, including psychotic disorders, remains unclear. Studies have shown positive associations between prolonged psychosocial adversity experienced in such populations and the development of schizophrenia. This case report describes a Black-African migrant woman who presented with first episode psychosis.
Click here to view

Treatment of psychosis in Huntington’s disease with clozapine
There is limited evidence relating to the treatment of psychotic symptoms in Huntington’s disease (HP); therefore, treatment decisions are based on clinical consensus and expert opinion. In this article, Dr Majothi et al. describe the use of clozapine in an unlicensed manner in HP, which proved to be safe and effective.
Click here to view

The COVID-19 pandemic and its impact on mental health
Similarities exist between our past experience of viral diseases and COVID-19 concerning the mental health issues of sufferers of an epidemic, frontline health workers and the social and psychological impact on society. There is significant evidence that a novel illness such as COVID-19 can cause widespread fear, panic, anxiety and xenophobia. Dr Chakraborty explores the latest literature and what it means for mental health.
Click here to view

Web design and marketing agency Leamington Spa